Ballentine Partners, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2018$87,000
+6.1%
27,1070.0%0.01%0.0%
Q2 2018$82,000
-22.6%
27,1070.0%0.01%
-16.7%
Q1 2018$106,000
-6.2%
27,1070.0%0.01%0.0%
Q4 2017$113,000
-32.3%
27,1070.0%0.01%
-33.3%
Q3 2017$167,000
+3.1%
27,1070.0%0.01%
-25.0%
Q2 2017$162,000
+252.2%
27,107
+23.8%
0.01%
+100.0%
Q2 2013$46,00021,8930.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders